DUET BIOTHERAPEUTICS
A Scopus BioPharma company creating targeted immunotherapies for treatment-resistant cancers.
DUET BIOTHERAPEUTICS
Industry:
Biotechnology
Founded:
2021-01-01
Address:
Pasadena, California, United States
Country:
United States
Website Url:
http://www.duettx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
TVAX Biomedical
TVAX Biomedical develops cell-based immunotherapy for the treatment of cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.duettx.com Semrush global rank: 5.89 M Semrush visits lastest month: 1.4 K
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Duet BioTherapeutics"
Duet BioTherapeutics - Crunchbase Company Profile & Funding
Organization. Duet BioTherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; โฆSee details»
Home - Duet Therapeutics
Creating targeted immunotherapies for treatment-resistant cancers.. Home; About; Approach; Pipeline; News & Resources; Contact; MenuSee details»
Duet BioTherapeutics | LinkedIn
Duet BioTherapeutics is an immunotherapy company creating a new category of bispecific oligonucleotide treatments designed to target dormant immune cells within the tumor โฆSee details»
Duet BioTherapeutics - VentureRadar
Duet BioTherapeutics is a clinical-stage immuno-oncology company creating a new category of bifunctional and cell-selective oligonucleotide... ... Find out more about ...See details»
Duet BioTherapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jul 1, 2023 Explore Duet BioTherapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Neoplasms, Immune System Diseases, Hemic โฆSee details»
Alan Horsager - President & CEO @ Duet BioTherapeutics
Website www.duettx.com ; LinkedIn View on LinkedIn ; Twitter View on Twitter ; Alan Horsager, Ph.D. is a life science executive developing genetic medicines for human diseases. His career โฆSee details»
Duet BioTherapeutics Overview | SignalHire Company Profile
Duet BioTherapeutics is an immunotherapy company creating a new category of bispecific oligonucleotide treatments designed to target dormant immune cells within the tumor โฆSee details»
Duet BioTherapeutics, Inc. (Duet BioTherapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma Data Suggests Benefits of Combinations of DUET-102 with Other โฆSee details»
Duet Therapeutics - Overview, News & Similar companies
Www.duettx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview ; Who is Duet Therapeutics. Duet โฆSee details»
SEC.gov | HOME
STAT3 as an I - O target 7 STAT3 is a master regulator of the immune system and a high - value immuno - oncology target, but requires cell - specific modulation Tumor cell STAT3 โข Immune โฆSee details»
duettx.com - Home - Duet Therapeutics - Duet Tx - Sur.ly
Duettx.com. Creating targeted immunotherapies for treatment-resistant cancers. sur.ly Home - Duet Therapeutics. Creating targeted immunotherapies for treatment-resistant cancers. โฆSee details»
Contact - Duet Therapeutics
Contact Us Corporate Headquarters 251 South Lake Avenue Suite 800 Pasadena, CA 91101 *Required FieldSee details»
Duet Therapeutics Set to Release Scientific Data
Sep 28, 2021 Scopus BioPharmaโs Subsidiary โ Duet Therapeutics โ Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics Society Duet โฆSee details»
Company Information - RocketReach
The most common Duet BioTherapeutics email format. is [first] (ex. [email protected]), which is being used by 100.0% of Duet BioTherapeutics work email addresses. Duet BioTherapeutics โฆSee details»
Team - Duet Therapeutics
Duet pairs invention with scientific rigor to develop solutions that restore human health. Duet Therapeutics is a clinical stage immuno-oncology company pioneering the development of โฆSee details»
Duet BioTherapeutics Email Format | Duettx.com Emails - SignalHire
Here are 6 email formats that are most likely used by the Duet BioTherapeutics, where firstNameInitial-lastName (ex. [email protected]) has the highest usage frequency - 55% of the โฆSee details»
Duett, Inc.
Duett is the fastest way for care coordinators to identify providers for care plans, the easiest way for providers to grow their business, and the best way for individuals to choose their care.See details»
Pipeline - Duet Therapeutics
Our Pipeline While Duet is dedicated to moving our drugs into the clinic as quickly as possible, these decisions are driven by scientific results. All our development-stage programs are โฆSee details»
Scientific Approach - Duet Therapeutics - duettx.com
Creating targeted immunotherapies for treatment-resistant cancers.. Home; About; Approach; Pipeline; News & Resources; Contact; MenuSee details»
News & Resources - Duet Therapeutics - duettx.com
Creating targeted immunotherapies for treatment-resistant cancers.. Home; About; Approach; Pipeline; News & Resources; Contact; MenuSee details»